1496:TSE:TSE-iShares USD Investment Grade Corporate Bond JPY Hedged ETF (JPY)

ETF | Others |

Last Closing

USD 1891

Change

0.00 (0.00)%

Market Cap

USD 43.87B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
1306:TSE Nomura TOPIX Listed

N/A

USD 23,611.00B
1308:TSE Nikko TOPIX Listed

N/A

USD 11,091.37B
1321:TSE Nomura Nikkei 225 Listed

N/A

USD 11,082.14B
1305:TSE Daiwa TOPIX Listed

N/A

USD 10,799.81B
1330:TSE Nikko Nikkei 225 Listed

N/A

USD 5,423.56B
1320:TSE Daiwa Nikkei 225 Listed

N/A

USD 5,181.88B
1348:TSE MAXIS TOPIX

N/A

USD 3,383.69B
1346:TSE MAXIS Nikkei 225

N/A

USD 2,731.89B
1475:TSE iShares Core TOPIX ETF

N/A

USD 1,877.98B
1591:TSE NEXT FUNDS JPX-Nikkei Index 40..

N/A

USD 1,666.73B

ETFs Containing 1496:TSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.17% 22% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.17% 22% F 52% F
Trailing 12 Months  
Capital Gain 3.45% 35% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.45% 35% F 61% D-
Trailing 5 Years  
Capital Gain -25.02% 16% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.02% 16% F 40% F
Average Annual (5 Year Horizon)  
Capital Gain -7.27% N/A N/A 11% F
Dividend Return -7.26% N/A N/A 11% F
Total Return 0.01% N/A N/A 1% F
Risk Return Profile  
Volatility (Standard Deviation) 8.35% N/A N/A 97% N/A
Risk Adjusted Return -86.92% N/A N/A 3% F
Market Capitalization 43.87B 71% C- 65% D

Annual Financials (JPY)

Quarterly Financials (JPY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike